the point estimate of protective efficacy was 54 % ( 95 % confidence intervals 26-72 % ) for the lpf-toxoid vaccine and 69 % ( 47-82 ) for the two-component vaccine ;
C3495466
toxoid vaccine
C0042210
vaccine